Zetiq and HCG Signed a Memorandum of Understanding for Collaboration in Commercializing the CellDetect® Cervical Cancer Diagnosis Product in India

Zetiq Technologies has signed a memorandum of understanding with HealthCare Global Entreprises Ltd. (HCG), the leading network of private oncology hospitals in India, for clinical validation and evaluation of the commercial market for its CellDetect® cervical cancer diagnostic product in India.

Link to complete article

More News/Information
© Micromedic Technologies Ltd. site mapcontact
 
Site by Site2goal | Design Studio Michal Lehavi